Digital Health Validation Lab Evidence Generation Bootcamp

Accelerate your HealthTech solution with our Evidence Generation Bootcamp!

Building on the success of our inaugural bootcamp last year, the Digital Health Validation Lab is proud to host its second edition on Wednesday 1st and Thursday 2nd of October. This two-day, hands-on event is designed for HealthTech innovators who are ready to accelerate their solutions and drive real-world impact.

In today’s fast-moving and competitive HealthTech landscape, robust evidence is critical to achieving regulatory approval, adoption, scale, and long-term success. This bootcamp provides a practical framework to help you confidently navigate the complexities of evidence generation and build a clear, actionable strategy aligned with your innovation and route to market.

💡 Through expert-led sessions, you'll gain:

• Clarity on your evidence requirements and how to address them effectively

• Confidence to engage key stakeholders with timely, relevant evidence and navigate complex evidence demands

• A personalised roadmap for evidence generation, tailored to your solution and market strategy

• Improved understanding of approaches to: Patient and Public Involvement (PPI); concept validation; health economic modelling; simulation; technical feasibility and AI performance testing; clinical investigations for regulatory approval; and clinical and cost-effectiveness studies to support adoption.

Who should attend?

HealthTech startups, SMEs, innovation leads, and academic researchers ready to turn a great solution into an evidence-backed, scalable success.

Agenda Overview

Please note: This is an outline of the key topics planned for the event. The full programme and detailed schedule will be announced soon.

Day 1 Highlights:

• Healthtech Evaluation: Defining health technologies, understanding evidence requirements, and mapping the journey from concept to clinic.

• Patient and Public Involvement and Engagement (PPIE): Integrating patient and public voices from product design through to clinical research.

• Concept Testing and Clinical Pathways: Validating concepts with patients and clinicians and aligning solutions within clinical workflows.

• Modelling, Simulation and Technical Feasibility: Early health economic modelling, assessing technical feasibility, planning NHS prospective studies, and more.

Day 2 Highlights:

• Medical Device Regulation: Navigating regulatory approval and evidence requirements, common challenges, and practical solutions.

• Health Economics, Health Technology Assessment and NICE Guidelines

• Investor Readiness: The vital role of evidence in securing investment, demystifying the VC model, and navigating the funding journey.

Stay tuned for the full agenda with detailed timings and session descriptions coming soon!

We’re thrilled to announce our headline speakers, with additional speakers to follow soon.

Professor Olivia Wu FRSE

Olivia holds the William R Lindsay Chair of Health Economics at the University of Glasgow and is Adjunct Professor of Health Technology Assessment (HTA) at Mahidol University in Thailand. Her research spans across a wide range of clinical areas but focuses on adapting and applying HTA methodologies in context. She has led numerous economic evaluations alongside clinical evaluations and trials, which influenced adoption decisions of health intervention (including drug and non-drug treatments, medical devices, and digital health technologies). Her work has informed clinical guidelines and health policy decisions, both at national and international levels.

Olivia collaborates widely and is chief and co-Investigators of active research projects with a cumulative value of over £50 million. In addition to her research, Olivia is a long-standing advisor to international HTA agencies. She has previously served as member of the NICE Technology Appraisal committee for 10 years. Currently, Olivia is the Director of the NIHR Better Methods Better Research Programme and of the National Research Collaboration Programme.

Professor Neil Hawkins

Professor Neil Hawkins is a Professor of Health Technology Assessment (HTA) at the University of Glasgow, where he brings decades of cross-sector experience to advancing evidence-based healthcare decision-making. His career spans academia, industry, and consultancy, with contributions across pharmacology, clinical development, epidemiology, and HTA.

Before joining academia, Neil held senior leadership roles in the private sector, including Vice President of Global Health Economics at ICON PLC and Board Director at Oxford Outcomes Ltd. His interdisciplinary background is supported by postgraduate degrees in pharmacology, health economics, and applied statistics, and he is a Chartered Statistician.

Alongside his academic role, Neil serves as a consultant in HTA to the pharmaceutical and medical device industries. He also contributes to national health policy as a member of several NICE committees, including serving as Vice-Chair of the NICE Diagnostics Advisory Committee.

Professor David Lowe

Professor David Lowe is an Emergency Consultant at Queen Elizabeth University Hospital (QEUH), Clinical Director of Innovation at the University of Glasgow, and Clinical Director for Health Innovation for the Scottish Government.

With extensive experience in creating the infrastructure and conditions to translate projects into viable healthcare solutions, David plays a leading role in advancing HealthTech innovation. He is the clinical lead for several initiatives developing and evaluating the deployment of AI and various medical imaging solutions within healthcare systems.

David has also led the development of several impactful digital health tools, such as Trauma App. He is the founder of the EmQuire research group, through which he supports and coordinates quality improvement, innovation, research, and education at QEUH and within its Emergency Department.

Ticket Price

£295.00 - Early Bird Rate (until 15 August 2025, 23.59 BST)

£350.00 - Standard Rate (from 16 August 2025, 00.00 BST)

Please note that registration will close on Friday 19 September, 12.00(BST)